Integrating bioinformatics and machine learning for comprehensive analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric septic shock.

Journal: Scientific reports
PMID:

Abstract

This study aims to predict and diagnose pediatric septic shock through the screening of immune infiltration-related biomarkers. Three gene expression datasets were accessible from the Gene Expression Omnibus repository. The differentially expressed genes were identified using the R 4.3.2 ( https://www.r-project.org/ ), followed by gene set enrichment analysis. Thereafter, the genes were identified utilizing machine-learning algorithms. The receiver operating characteristic curve was employed to assess the discrimination and effectiveness of the hub genes. The inflammatory and immune status of pediatric septic shock was evaluated through cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT). The correlation between diagnostic markers and infiltrating immune cells was further examined. Overall, we detected 12 differentially expressed genes. CD177, MCEMP1, MMP8, and OLAH were examined as diagnostic indicators for pediatric septic shock, revealing statistically significant differences (P < 0.01) and diagnostic efficacy in the validation cohort. The immune cell infiltration analysis suggests that various immune cells may contribute to the onset of pediatric septic shock. Furthermore, all diagnostic characteristics may exhibit varying degrees of correlation with immune cells. This study identifies four potential biomarkers-CD177, MCEMP1, MMP8, and OLAH-that provide diagnostic value and novel insights into immune dysregulation in pediatric septic shock. Through the integration of bioinformatics and machine learning methodologies, we offer a novel perspective on the immune mechanisms involved in pediatric septic shock, potentially facilitating more targeted and personalized therapies for individual patients.

Authors

  • Peng Lyu
    Department of Emergency, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Na Xie
  • Xu-Peng Shao
    Department of Emergency, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Shuai Xing
    Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiao-Yue Wang
    Department of Emergency, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Li-Yun Duan
    First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Xue Zhao
    Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China; Department of Breast-Thyroid-Surgery and Cancer Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; Xiamen Research Center of Clinical Medicine in Breast & Thyroid Cancers, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; Xiamen Key Laboratory of Endocrine-Related Cancer Precision Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Jia-Min Lu
    First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Rong-Fei Liu
    First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
  • Duo Zhang
    Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, China.
  • Wei Lu
    Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Kai-Liang Fan
    Department of Emergency, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China. 18560769418@163.com.